Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
5000 participants
OBSERVATIONAL
2022-08-11
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Develop new ways of finding and diagnosing lung health problems, such as lung cancer.
* Develop tools which make it easier to screen people with possible lung health problems, diagnose problems earlier and with fewer tests, and start the best treatment faster.
* Help improve the early diagnosis of lung cancer, as finding lung cancer early means that it can be treated more easily and successfully.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program
NCT03628638
Early Cancer Detection Test - Lung Cancer Scotland
NCT01925625
Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung
NCT05987189
Collection of Blood Samples in Patients With Non-small Cell Lung Cancer
NCT03492801
Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers
NCT00899262
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Willing and able to give informed consent
Exclusion Criteria
55 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Innovate UK
OTHER_GOV
Optellum
UNKNOWN
National Institute for Health Research, United Kingdom
OTHER_GOV
Cancer Research UK
OTHER
GE Healthcare
INDUSTRY
Prenostics
UNKNOWN
Roche Diagnostics GmbH
INDUSTRY
University of Oxford
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Lee
Role: PRINCIPAL_INVESTIGATOR
Royal Marsden NHS Foundation Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lung Health Check: Oxford - Churchill Hospital, OUH
Oxford, Oxfordshire, United Kingdom
Lung Health Check Centre: Royal Sussex
Brighton, , United Kingdom
Lung Health Check Centre: North Bristol
Bristol, , United Kingdom
Lung Health Check Centre: Gateshead
Gateshead, , United Kingdom
Lung Health Check Centre: Corby & Kettering
Kettering, , United Kingdom
Lung Health Check Centre: Cheshire & Merseyside
Liverpool, , United Kingdom
Lung Health Check Centre: RM Partners
London, , United Kingdom
Lung Health Check Centre: Newcastle & Gateshead
Newcastle, , United Kingdom
Lung Health Check Centre: Plymouth
Plymouth, , United Kingdom
Lung Health Check Centre: Stoke
Stoke, , United Kingdom
Lung Health Check Centre: South Tyneside and Sunderland
Sunderland, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jenny Messenger
Role: primary
Anna Bibby
Role: primary
Ruth Sharrock
Role: primary
George Tsaknis
Role: primary
Martin Ledson
Role: primary
Richard Lee
Role: primary
Liz Fuller
Role: primary
Cyrus Daneshvar
Role: primary
Imran Hussain
Role: primary
Nadia Elkaram
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
OCTO webpage containing information about the SCOOT trial
Cancer Research UK webpage containing information about the Lung Health Check programme
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OCTO-106
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.